Geron GERN
NASDAQ GERN
$1.10 -0.03 (-3.10%)
As of: Oct 23, 2026 · 2:28 PM EDT

Geron (GERN) Return on Sales [ROS] (2010 - 2026)

Updated

Geron's Return on Sales [ROS] came in at -21.74% for Q2 2026, up 3.66 percentage points from -25.40% a year earlier but down 22.04 percentage points from the prior quarter.

Analysis

Geron (GERN) Return on Sales [ROS] (2010 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Geron reported Return on Sales [ROS] of -21.23%, up 22.54 percentage points year-over-year; for FY2025, it came in at -30.74%, up 163.55 percentage points from FY2024.

  • Return on Sales [ROS] carries a five-year change of +30369.66 percentage points (FY2020 to FY2025).
  • Going back by year, Return on Sales [ROS] was -194.29% in FY2024 (+81638.62 pp), -81832.91% in FY2023 (-58586.27 pp), -23246.64% in FY2022 (-15062.94 pp) and -8183.70% in FY2021 (+22216.69 pp).
  • The five-year range for quarterly Return on Sales [ROS] is -236039.13% (Q4 2023) to 0.30% (Q1 2026).
  • Year-over-year, Return on Sales [ROS] has increased for ten consecutive quarters, with an average year-over-year change of +36414.59 percentage points over the last eight quarters.
  • The fastest year-over-year change in Return on Sales [ROS] over five years came in Q4 2024 (a gain of 236005.69 percentage points), and the weakest in Q4 2023 (a drop of 195310.00 percentage points).
  • Business Quant data shows GERN's Return on Sales [ROS] at 0.30% (Q1 2026), -29.27% (Q4 2025) and -29.40% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,128.99 Bn 1,097.58 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 634.51 Bn 554.37 Bn 17.30 Bn 24.35%
3 AbbVie 505.90 Bn 479.01 Bn 12.70 Bn 37.86%
4 Merck 357.53 Bn 311.91 Bn 12.21 Bn -3.52%
5 Novartis Ag 289.94 Bn 253.93 Bn 11.24 Bn 32.97%
6 Astrazeneca 265.41 Bn 239.09 Bn 12.86 Bn 20.57%
7 Amgen 238.14 Bn 193.54 Bn 7.24 Bn 34.95%
8 Gilead Sciences 194.79 Bn 168.99 Bn 6.22 Bn -133.21%
9 Pfizer 171.00 Bn 117.64 Bn 10.94 Bn 28.37%
10 Geron 733.69 Mn -618.01 Mn - -21.74%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -21.74%
Mar 31, 2026 0.30%
Dec 31, 2025 -29.27%
Sep 30, 2025 -29.40%
Jun 30, 2025 -25.40%
Mar 31, 2025 -42.18%
Dec 31, 2024 -33.44%
Sep 30, 2024 -99.80%
Jun 30, 2024 -7,860.88%
Mar 31, 2024 -18,465.13%
Dec 31, 2023 -236,039.13%
Sep 30, 2023 -29,031.71%
Jun 30, 2023 -179,141.38%
Mar 31, 2023 -190,914.29%
Dec 31, 2022 -40,729.13%
Sep 30, 2022 -13,450.51%
Jun 30, 2022 -38,323.29%
Mar 31, 2022 -23,313.01%
Dec 31, 2021 -2,979.04%
Sep 30, 2021 -23,554.13%
API Access

Geron Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=GERN&period=max&api_key=YOUR_API_KEY